Funds › Pavaki Capital Management LLC
Pavaki Capital Management LLC
13F for Q3 2026, filed Oct 26, 2026. 132 positions worth $294.2M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Oct 26, 2026
Reported value
$294.2M
+$7.4M (2.6%) vs Q2 2026
Positions
132
132 in Q2 2026
Top 10 share
38.8%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Pavaki Capital Management LLC in the latest 13F quarter?
Using 13F.ai, how has Pavaki Capital Management LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Pavaki Capital Management LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | NVDA NVIDIA Corporation | 130,000 | $29.7M | 10.1% | +400% | 13F ↗ |
| 2 | CVX Chevron Corporation | 103,000 | $21.0M | 7.1% | +6.2% | 13F ↗ |
| 3 | INTU Intuit Inc. | 38,600 | $10.6M | 3.6% | Unchanged | 13F ↗ |
| 4 | B Barrick Mining Corporation | 226,500 | $9.2M | 3.1% | +2.3% | 13F ↗ |
| 5 | QCOM QUALCOMM Incorporated | 49,000 | $9.0M | 3.1% | Unchanged | 13F ↗ |
| 6 | REGN Regeneron Pharmaceuticals, Inc. | 11,300 | $8.6M | 2.9% | +14.1% | 13F ↗ |
| 7 | MIST Milestone Pharmaceuticals Inc. | 9.34M | $8.1M | 2.7% | +3.0% | 13F ↗ |
| 8 | TXT Textron Inc. | 90,800 | $6.9M | 2.4% | +7.7% | 13F ↗ |
| 9 | BTG B2Gold Corp | 1.18M | $6.2M | 2.1% | Unchanged | 13F ↗ |
| 10 | ARQT Arcutis Biotherapeutics, Inc. | 187,000 | $4.9M | 1.7% | Unchanged | 13F ↗ |
| 11 | MU Micron Technology, Inc. | 4,000 | $4.3M | 1.4% | Unchanged | 13F ↗ |
| 12 | CGAU Centerra Gold Inc. | 177,000 | $3.9M | 1.3% | -10.2% | 13F ↗ |
| 13 | NEM Newmont Corporation | 32,500 | $3.7M | 1.3% | Unchanged | 13F ↗ |
| 14 | LGND Ligand Pharmaceuticals Incorporated | 11,100 | $3.5M | 1.2% | Unchanged | 13F ↗ |
| 15 | SLB SLB Limited | 61,000 | $3.0M | 1.0% | Unchanged | 13F ↗ |
| 16 | HRMY Harmony Biosciences Holdings, Inc. | 73,000 | $2.9M | 1.0% | Unchanged | 13F ↗ |
| 17 | SPRY ARS Pharmaceuticals, Inc. | 659,600 | $2.8M | 1.0% | +13.8% | 13F ↗ |
| 18 | RPRX Royalty Pharma plc | 44,000 | $2.6M | 0.9% | Unchanged | 13F ↗ |
| 19 | BIO Bio-Rad Laboratories, Inc. Class A | 6,000 | $2.3M | 0.8% | Unchanged | 13F ↗ |
| 20 | SKYD Skydance Corporation | 208,863 | $2.2M | 0.7% | Unchanged | 13F ↗ |
| 21 | iShares Inc Msci Singpor Etf | 60,000 | $2.0M | 0.7% | Unchanged | 13F ↗ |
| 22 | FSK FS KKR Capital Corp. | 180,100 | $2.0M | 0.7% | +12.5% | 13F ↗ |
| 23 | SSRM SSR Mining Inc. | 53,000 | $1.8M | 0.6% | -29.3% | 13F ↗ |
| 24 | NAMS NewAmsterdam Pharma Company N.V. | 66,600 | $1.6M | 0.6% | Unchanged | 13F ↗ |
| 25 | DOUG Douglas Elliman Inc. | 1.02M | $1.6M | 0.5% | Unchanged | 13F ↗ |
| 26 | HAL Halliburton Company | 46,000 | $1.5M | 0.5% | Unchanged | 13F ↗ |
| 27 | iShares Tr Msci Philips Etf | 58,000 | $1.3M | 0.4% | Unchanged | 13F ↗ |
| 28 | YUMC Yum China Holdings, Inc. | 30,000 | $1.2M | 0.4% | Unchanged | 13F ↗ |
| 29 | KGC Kinross Gold Corporation | 49,500 | $1.2M | 0.4% | Unchanged | 13F ↗ |
| 30 | BIDU Baidu, Inc. · ADR | 13,000 | $1.1M | 0.4% | Unchanged | 13F ↗ |
| 31 | SNDX Syndax Pharmaceuticals, Inc. | 60,000 | $1.1M | 0.4% | Unchanged | 13F ↗ |
| 32 | OGC OceanaGold Corporation | 40,200 | $1.1M | 0.4% | Unchanged | 13F ↗ |
| 33 | EQX Equinox Gold Corp. | 91,000 | $1.0M | 0.3% | -9.0% | 13F ↗ |
| 34 | RMR The RMR Group Inc. | 55,500 | $1.0M | 0.3% | +56.3% | 13F ↗ |
| 35 | BBD Banco Bradesco Sa · ADR | 264,336 | $930.5K | 0.3% | Unchanged | 13F ↗ |
| 36 | UBS UBS Group AG | 19,000 | $915.9K | 0.3% | Unchanged | 13F ↗ |
| 37 | ERIC Ericsson · ADR | 97,500 | $892.1K | 0.3% | Unchanged | 13F ↗ |
| 38 | RGLD Royal Gold, Inc. | 3,750 | $885.0K | 0.3% | Unchanged | 13F ↗ |
| 39 | OSUR OraSure Technologies, Inc. | 219,033 | $858.6K | 0.3% | Unchanged | 13F ↗ |
| 40 | ICLR ICON plc | 5,000 | $850.0K | 0.3% | Unchanged | 13F ↗ |
| 41 | SNY Sanofi | 20,000 | $824.6K | 0.3% | Unchanged | 13F ↗ |
| 42 | BKR Baker Hughes Company | 15,000 | $823.5K | 0.3% | Unchanged | 13F ↗ |
| 43 | KSPI Joint Stock Company Kaspi.kz · ADR | 8,700 | $818.3K | 0.3% | Unchanged | 13F ↗ |
| 44 | BIIB Biogen Inc. | 3,500 | $790.6K | 0.3% | Unchanged | 13F ↗ |
| 45 | MRK Merck & Company, Inc. | 5,000 | $726.5K | 0.2% | Unchanged | 13F ↗ |
| 46 | LNTH Lantheus Holdings, Inc. · Commonstock | 7,100 | $706.7K | 0.2% | Unchanged | 13F ↗ |
| 47 | KBR KBR, Inc. | 20,000 | $703.2K | 0.2% | Unchanged | 13F ↗ |
| 48 | ITUB Itau Unibanco Banco Holding SA · ADR | 82,400 | $702.9K | 0.2% | Unchanged | 13F ↗ |
| 49 | CLBT Cellebrite DI Ltd. | 60,000 | $675.6K | 0.2% | Unchanged | 13F ↗ |
| 50 | DHC Diversified Healthcare Trust · Com Sh Ben Int | 85,000 | $667.3K | 0.2% | Unchanged | 13F ↗ |
Showing the top 50 of 132 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
9 new, 10 added to, 4 trimmed, 9 exited, 109 unchanged. By estimated dollars.
New positions (9)
| CAI Caris Life Sciences, Inc. | 20,000 | New | $612.6K |
| REAX Real REMAX Group Inc. | 12,875 | New | $210.6K |
| HII Huntington Ingalls Industries, Inc. | 700 | New | $186.9K |
| NVCT Nuvectis Pharma, Inc. | 7,500 | New | $158.4K |
| HONA Honeywell Aerospace Inc. | 1,000 | New | $155.0K |
| GNLX Genelux Corporation | 60,000 | New | $151.8K |
| ODTX Odyssey Therapeutics, Inc. | 5,000 | New | $111.1K |
| EIKN Eikon Therapeutics, Inc. | 10,000 | New | $80.4K |
| WVE Wave Life Sciences, Inc. | 15,000 | New | $55.5K |
Added to (10)
| NVDA NVIDIA Corporation | 130,000 | +400% | $23.8M |
| CVX Chevron Corporation | 103,000 | +6.2% | $1.2M |
| REGN Regeneron Pharmaceuticals, Inc. | 11,300 | +14.1% | $1.1M |
| TXT Textron Inc. | 90,800 | +7.7% | $495.3K |
| RMR The RMR Group Inc. | 55,500 | +56.3% | $361.6K |
| SPRY ARS Pharmaceuticals, Inc. | 659,600 | +13.8% | $344.8K |
| MIST Milestone Pharmaceuticals Inc. | 9.34M | +3.0% | $233.7K |
| FSK FS KKR Capital Corp. | 180,100 | +12.5% | $219.8K |
| B Barrick Mining Corporation | 226,500 | +2.3% | $203.3K |
| NVO Novo Nordisk A/S · ADR | 9,500 | +111% | $189.5K |
Trimmed (4)
Exited (9)
| AMD Advanced Micro Devices, Inc. | 4,000 | Exited | -$2.3M |
| NOK Nokia Corporation Sponsored · ADR | 70,000 | Exited | -$929.6K |
| REPL Replimune Group, Inc. | 80,400 | Exited | -$890.0K |
| INTC Intel Corporation | 4,000 | Exited | -$558.5K |
| ARIS Aris Mining Corporation | 30,000 | Exited | -$447.3K |
| Catalyst Pharmaceuticals Inc | 8,000 | Exited | -$251.4K |
| Re/Max Holdings Inc | 25,000 | Exited | -$246.5K |
| PEB Pebblebrook Hotel Trust | 12,000 | Exited | -$232.9K |
| Wave Life Sciences Ltd | 15,000 | Exited | -$87.2K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer